BioLife4D Corporation (SAVU)

BioLife4D Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2021	Dec 31, 2020
Net Income	-1.96	-1.5	-1.7
Depreciation & Amortization	0.01	0.01	0.01
Share-Based Compensation	-	0.63	0.21
Other Operating Activities	0.74	-0.26	0.02
Operating Cash Flow	-1.21	-1.12	-1.46
Capital Expenditures	-0.02	-	-0.01
Investing Cash Flow	-0.02	-	-0.01
Share Issuance / Repurchase	-	1.57	0.57
Debt Issued / Paid	-	0.17	-0.03
Other Financing Activities	1.23	-0.03	-0.08
Financing Cash Flow	1.23	1.72	0.46
Net Cash Flow	0.01	0.6	-1
Free Cash Flow	-1.22	-1.12	-1.47

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).